Across TCGA pan-cancer cohorts, ZNF971P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of ZNF971P’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where ZNF971P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF971P is over-expressed in tumor.
BRCA are the cancer types where ZNF971P tumor–normal differential expression is most reproducible.